Cold plasmas induce angiogenesis, enhance coagulation and wound healing, and selectively ablate microbes without harming eukaryotes. Work on bone tissue has been minimal; initial studies show enhanced osseointegration, increased gene transcription, and mesenchymal stem cell growth. Mesenchymal stem cell osteoblastic differentiation is required for bone formation and healing. The present study employs a novel device to assess whether cold argon plasma induces osteogenic differentiation of human mesenchymal stem cells. Human -ionized argon gas, argon plasma, and argon plasma with osteogenic stimulation. Known osteoblastic differentiation markers (alkaline phosphatase, osteocalcin, RANKL) were assessed on days 1, 10, and 28. Cellular DNA production was measured for normalization. Novel dielectric distance 22 mm, and duration 30 sec. Alkaline phosphatase level was decreased compared to -line phosphatase (p < 0.0014) compared to other groups. Osteogenic stimulation did not result in difference from growth. Changes in osteocalcin or receptor activator of nuclear factor kappa-B ligand (RANKL) were not observed. plasma to induce osteoblastic differentiation cannot be made. Lack of -glycerophosphate addition on day 14 prevented osteogenic media from responding as expected. Interestingly, nonpossibly due to argon shielding or shear force production, merits further study.
I. INTRODUCTION
ciplines of plasma physics, engineering, and biology to exert effects on biological tissue. "Plasma" refers to the application of plasma as the fourth state of matter-a cloud of -1, 2 There are many different types of plasmas and different methods to create them, but the most appropriate for living tissue use are called nonthermal atmospheric pressure plasma (NTAPP) or cold atmospheric plasma (CAP).
1 They are so named because they function at much lower temperatures and pressures than other more familiar forms of plasma, such as stars.
The effects of CAP on living tissue are far-reaching, affecting a myriad of different cell populations and biological processes. CAP exposure has demonstrated the following broad effects: (1) inducing angiogenesis by increasing endothelial cell migration and proliferation 1, 3, 4 ; (2) ; (9) accelerating blood coagulation by effects on coagulation proteins, platelet aggregation, 1,9,21 ; (10) accelerating wound healing 1, 22, 23 ; (11) inducing changes in cell surface receptors 24, 25 ; and (12) displaying various effects on lymphocyte subpopulations. 26 To date, minimal work has been done investigating the effects of CAP on bone tissue. Previous studies in animal dental and tibial implants, 27-31 32-37 and cell culture [38] [39] [40] show initial promise. These experiments demonstrated enhanced implant osseointegration [27] [28] [29] [30] [31] 33, 34, 36, 37, 41 (measured by surface hydrophilicity, removal torque, -genic gene transcripts and mesenchymal stem cell growth. 2, 36, [38] [39] [40] One possible explanation for these phenomena is that CAP induces mesenchymal stem cell (MSC) differentiation into osteoblasts, resulting in the previously mentioned enhanced osseointegration assessed the potential for nonthermal plasma to convert MSCs into osteoblasts.
It is known that increased MSC osteoblastic differentiation results in accelerated and enhanced fracture healing. 42, 43 Therapies such as bone morphogenetic protein 44 are emosteolysis and postoperative radiculitis, and great expense. 45 Nonthermal plasma has been shown to be safe when applied to eukaryotic cells.
1,7-17 If osteoblastic differentiation of MSCs can be demonstrated, it holds future promise as an orthopedic surgical adjunct in situations such as the treatment of nonunion fractures and spinal fusion. The present study employs a novel dielectric barrier discharge device for nonthermal atmospheric pressure plasma creation, aiming to ascertain if cold atmospheric argon plasma induces human MSCs to differentiate into the osteoblastic lineage.
II. MATERIALS & METHODS

A. Sample Selection
The human MSCs were acquired from three human donors from the laboratory of James groups were assessed with measurement of alkaline phosphatase, receptor activator of nuclear factor kappa-B ligand (RANKL), osteocalcin, and DNA assays at three time was assessed in triplicate for all four assays at all three time points. All assays were assessed at each time point except for RANKL and osteocalcin, which were not assessed for argon gas (group 3) and argon plasma (groups 4 and 5) are detailed next.
C. Nonthermal Argon Plasma Device and Exposure Parameters
This experiment employed a novel device (Figs. 1 and 2) for nonthermal atmospher-(Champaign, IL). Several unique characteristics allow enhanced nonthermal plasma delivery. This device is a hybrid combination of dielectric barrier discharge (DBD) and -mal plasma several centimeters from the device tip. This permits conformal nonthermal plasma coverage over surfaces, penetration into wounds or cavities, and placement of sheaths on surfaces to increase ion energy at atmospheric pressures. Frequency can also be titrated from low-frequency AC/pulsed (kHz) to high-frequency (MHz/GHz). The -els. The dielectric surface itself can be either alumina or glass, and the dielectric barrier limits transferrable charge, minimizing streamer transition and direct-metal arcs. These features allow simultaneous creation of both direct and indirect nonthermal plasma, and ing distance compared to other DBD devices. The argon plasma parameters for the present study were as follows: energy level 6-well (35 mm) plates. Parameters were selected based on a literature review of operating parameters for nonthermal atmospheric pressure plasma devices. Argon gas for the experiment was purchased in a T type cylinder (330 cu ft) from Matheson Tri-Gas (Houston, TX).
D. In vitro Osteogenic Induction of Human Mesenchymal Stem Cells
Human mesenchymal stem cell differentiation was accomplished through exposure to dexamethasone and ascorbic acid. The cells were initially thawed at room temperature. The osteogenic-supplemented (OS) culture media consisted of FBS containing -7 M dexamethasone and 120 nM ascorbic acid 2-phosphate. Cells were counted and seeded at 5 × 10 3 per cm 2 in serum containing medium on 6-well (35 mm) plates and grown to approximately 70%-80% con- experimental process.
E. Alkaline Phosphatase Assay
The cells were assessed using a quantitative alkaline phosphatase activity assay. Cellular production of alkaline phosphatase typically reaches peak levels between 9 and 12 days after plating. For the quantitative biochemical assay, alkaline phosphatase cleaves a phosphate ion from p-nitrophenyl phosphate. The product, p-nitrophenol, is then added to a solution containing sodium hydroxide and the absorbance of the resulting solution is read at 405 nm with a Tecan microplate reader. The measured results were then compared to a standard curve that was also generated.
F. Osteocalcin and RANKL Enzyme-Linked Immunosorbent Assay (ELISA)
The human osteocalcin and RANKL levels were measured in cell culture supernatants using enzyme-linked immunosorbent assay (ELISA) kits, purchased from R&D Systems, Inc. (Minneapolis, Minnesota). The measurements were completed in triplicate, and the optical density was determined at 540 nm using a Tecan plate reader. Sensitivity of the osteocalcin assay was 0.402 ng/mL. The intra-assay and inter-assay precision log graph by plotting the mean absorbance for each standard against the concentration. Concentration of RANKL in the plates was determined by plotting the mean absorbance for each standard against the concentration.
G. DNA Assay
The Hoechst dye method was used to assess for cellular DNA production, permitting normalization of data per cell number. The samples from the 6-well (35 mm) plates were collected and 50 μl was placed in wells on 96-well black plates; 100 μl of Hoechst dye was added to each well, and the plates were read at an excitation of 365 nm and emission fusion plate reader. The data were assessed using a standard curve generated through the same protocol with a calf thymus DNA standard.
H. Statistical Analysis
Statistical analysis was performed with the assistance of Wei Zhang, Ph.D. at the Outcomes & Impact Service at Texas Children's Hospital in Houston, Texas. A generalized linear model was applied to assess group and donor effects. Analysis was performed for overall group and donor effects, pairwise group comparisons, and pairwise group comparisons with each of the three human donors.
III. RESULTS
tal groups at each of the three time points (days 1, 10, and 28). Cellular production of DNA was assessed to allow normalization of these three metrics per cell number. For normalization, two wells per donor per group per time point were considered for alkaline phosphatase, and one well per donor per group per time point was considered for osteocalcin and RANKL. Figures 3, 4 , and 5 demonstrate normalized measurements of alkaline phosphatase, osteocalcin, and RANKL.
FIG. 3:
Normalized alkaline phosphatase levels for groups 1-5 at days 1, 10, and 28. The x-axis represents duration of the experiment, from day 0 to day 28. The y-axis represents nmol/mL/min of alkaline phosphatase per ng/mL of DNA Of note, group 1 (growth media only) was not assessed for osteocalcin and RANKL. Time point 1 (day 1) for groups 3-5 was also not assessed for osteocalcin and RANKL.
The results for pairwise comparison for group and donor are described in Tables 1 to  3 . Pairwise comparisons of osteocalcin and RANKL with respect to each donor were not value (day 1) and "Growth Rate" refers to the speed of growth, taking into account all three time points to estimate the slope of the line in the plots.
FIG. 4:
Normalized osteocalcin levels for group 2 at days 1, 10, and 28, and for groups 3-5 at days 10 and 28. The x-axis represents duration of the experiment, from day 0 to day 28. The yaxis represents ng/mL of osteocalcin per ng/mL of DNA 
FIG. 5:
Normalized RANKL levels for group 2 at days 1, 10, and 28, and for groups 3-5 at days 10 and 28. The x-axis represents duration of the experiment, from day 0 to day 28. The y-axis represents pg/mL of RANKL per ng/mL of DNA.
production were observed at baseline. During the growth period, nonionized argon gas compared to group 1 (0.000246, p < 0.0001), group 2 (0.000247, p < 0.0001), group 4 (0.00025, p < 0.0001), and group 5 (0.00009, p = 0.0013). Argon plasma (group 4) decreased alkaline phosphatase levels compared to all other groups, with varying levels changes in any of the experimental groups in terms of levels of osteocalcin and RANKL at the three time points. [28] [29] [30] [31] 33, 34, 36, 37, 41, 47 and increased production of osteogenic gene transcripts and mesenchymal stem cell growth. 2, 36, [38] [39] [40] These initial experiments are promising in the study of bone formation and clinical applications in orthopedic surgery, because MSC differentiation into osteoblasts is a necessary step in bone healing. 43, 44 If 4 0.000193 <0.0001 0.000150 <0.0001 0.000135 0.0003 G1: growth media; G2: osteogenic media + growth media; G3: nonionized argon gas + growth media; G4: argon plasma + growth media; G5: argon plasma + osteogenic media + growth media nonthermal plasma can indeed induce human mesenchymal stem cells to differentiate into the osteoblastic lineage, it has the potential to positively impact bone healing and current therapeutics such as bone morphogenetic proteins. 45 atmospheric argon plasma to induce hMSC differentiation into osteoblasts. The osteogenic group (group 2) was meant to serve as a positive control for hMSC differentiation into the osteoblastic lineage. However, a lapse occurred in the addition of -glycerophosphate (BGP) on day 14 of the experiment. Along with dexamethasone and ascorbic acid, BGP is necessary for in vitro osteogenic differentiation of MSCs. 48 BGP addition on day 14 allows for mineralization of preosteoblastic cells; without it, a necessary step in MSC osteogenic differentiation cannot occur. Lacking this known control, we are CAP's inherent inability to trigger such a response, or rather a consequence of nonreactive donor cells. Furthermore, this limited our study of the combination group (group 5), because the osteogenic media was incomplete. The fact that BGP must be added on day 14, two weeks after dexamethasone and ascorbic acid, increases the probability of error. It is imperative that future researchers enact stringent methodologies to prevent similar lapses.
Another point of consideration for future study is single versus successive nonthermal plasma exposure. Human MSCs in our study were exposed to a single treatment of CAP, for the purpose of modeling the device as a potential adjunct during orthopedic surgeries. In a surgical setting, the increased morbidity from repeatedly opening a surgiachieved through the adjunct. Other in vitro nonthermal plasma studies have employed multiple plasma treatments over the duration of experiments. 8, 19, 22 This repeat exposure to nonthermal plasma may play a factor as mesenchymal stem cells progress through the three main stages of osteoblastic differentiation. 49 Future studies employing multiple -ferentiation stages to fully commit to the osteoblastic lineage. mesenchymal stem cell production of alkaline phosphatase. A prior study by Shuvalova et al. 50 demonstrated that mesenchymal stem cells exposed to a gas mixture containing high concentrations of argon gas (93%) led to enhanced MSC proliferation. However, increased alkaline phosphatase production by human MSCs exposed to argon gas has hypoxic environment above the MSCs, in a process called argon shielding (also referred to as argon blanketing). 51, 52 This refers to the use of inert gases, such as argon, in steel welding to shield a site of interest from oxygen and water vapor. In biological application, argon shielding will naturally create a local hypoxic climate due to its higher molecular weight and density compared to atmospheric air. Additionally, the production of shear forces by the argon gas stream may also be a contributing factor. The anaerobic environment from argon shielding and the shear force from the gas stream may trigger a stress response in human MSCs, resulting in increased metabolic activity and enhanced production of cellular factors such as alkaline phosphatase. The fact that groups 4 and 5 did not exhibit increased hMSC alkaline phosphatase production may indicate that ionization of argon into plasma prevents argon shielding and/or shear force production. The creation of smaller molecules and charged species within the plasma 1,2 may somehow interfere with shielding and shearing effects. Future studies assessing MSC response to nonionized gas mixture, and MSC production of other molecules in addition to alkaline phosphatase.
--ments of osteocalcin and RANKL had to be eliminated for group 1 (growth media only) and for time point 1 (day 1) for groups 3 to 5, because of the cost associated with ELISAs.
Ultimately, the present study is inconclusive in demonstrating whether cold atmospheric argon plasma causes osteogenic induction of human mesenchymal stem cells. The lapse in BGP addition invalidated the osteogenic positive control. Thus, we are -tive cells or the inability of CAP to trigger such a response. Future studies with proper controls should reveal the effects of single and repeat nonthermal plasma application on hMSC osteoblastic differentiation. Finally, a single exposure to nonionized argon gas possibly resulting from cellular response to argon shielding and/or shear forces, merits further exploration.
